Across TCGA pan-cancer cohorts, MIR1293 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR1293’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MIR1293 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR1293 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

BRCA, STAD, and BLCA are the cancer types where MIR1293 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR1293 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	IV	+0.835	<.001	2	view →
STAD	All	All	+0.569	.039	2	view →
BLCA	Male	IV	+0.675	.025	1	view →
KICH	Male	III,IV	−0.647	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR1293 RNA expression & survival · all MIR1293 data types